Schmidt & Clark, LLP | A National Law Firm

Kombiglyze Lawyer


Schmidt & Clark, LLP is no longer taking these cases

Our Kombiglyze lawyers may be able to assist people who took Kombiglyze to treat type-2 diabetes and developed cancer (particularly pancreatic cancer and thyroid cancer). Although Kombiglyze has only been on the market for a few years, there is growing evidence linking it to a risk of cancer. Our lawyers are concerned that the drug manufacturers failed to warn about this devastating, life-threatening side effect.

Free Kombiglyze Lawyer Evaluation: If you or your loved one was injured by pancreatic cancer or thyroid cancer after taking Kombiglyze, contact our law firm immediately for a free case consultation. If you file a lawsuit, you could receive compensation for your injury, medical expenses, and more.

Kombiglyze Lawyer

Our Kombiglyze lawyers are concerned about the growing amount of evidence suggesting a potential link between Kombiglyze, pancreatic cancer, and thyroid cancer. We are also concerned about the lack of warnings for many people who used Kombiglyze and developed cancer. Cancer is one of the most serious, devastating side effects that any medication can cause — both financially and physically — and there is no excuse for failing to warn about this risk.

Our Kombiglyze lawyers can help you file a lawsuit for:

  • Pain and suffering
  • Medical expenses (past and future)
  • Permanent injuries
  • Lost income
  • Decreased quality or enjoyment of life
  • Wrongful death of your family member
  • Punitive damages against the drug-maker

What is Kombiglyze XR?

Kombiglyze XR (saxagliptin and metformin) is an extended-release oral medication that is used to control blood-sugar in people with type-2 diabetes. It works by increasing the amount of a hormone that causes cells in the pancreas to produce insulin. Insulin is a hormone that tells cells to absorb more blood-sugar, which has the effect of reducing blood-sugar to a more normal level. The active drug in Kombiglyze was approved in 2009, Kombiglyze XR has been on the market since 2010, and it belongs to a new class of diabetes drugs called “incretin mimetics.”

FDA Safety Warnings for Kombiglyze and Pancreatic Cancer

Incretin mimetics are some of the newest diabetes drugs on the market, and there is simply no long-term safety data. Researchers are closely watching patients on these drugs for signals of unanticipated side effects. In one study, researchers examined the pancreases of patients who took an incretin mimetic and died from unspecified causes. Unfortunately, they found evidence of pancreatitis (chronic pancreas inflammation) and pre-cancerous cellular changes called pancreatic duct metaplasia. In March 2013, the FDA issued a Safety Communication to warn about the potential risk of Kombiglyze and pancreatic cancer.

Kombiglyze and Cancer

Kombiglyze and other “incretin mimetic” drugs have been associated with at least two cancers:

  • Pancreatic cancer: The active drug in Kombiglyze specifically targets the pancreas, which may increase the risk of inflammation (pancreatitis) — one of the biggest risk-factors for pancreatic cancer. Two of the most popular incretin mimetics, Januvia (sitagliptin) and Byetta (exenatide), were linked to dozens of cases of pancreatic cancer in a study published in Gastroenterology in 2011. Because these drugs are far more popular than Kombiglyze, these reports may indicate a link between Kombiglyze and pancreatic cancer.
  • Thyroid cancer: Because this cancer is extremely rare, it is difficult to study. However, the FDA published a Safety Communication after another “incretin mimetic” drug, Victoza (liraglutide), caused malignant thyroid tumors in rodents. Victoza and Kombiglyze are similar drugs, but the risk of Kombiglyze and thyroid cancer is still being investigated.

Do I have a Kombiglyze Lawsuit?

The Product Liability & Defective Drug Litigation Group at our law firm is an experienced team of trial attorneys that focus on the representation of plaintiffs in Kombiglyze lawsuits. We are handling individual litigation nationwide and currently accepting new lawsuits in all 50 states.

Free Kombiglyze Lawsuit Evaluation: Again, if you or a loved one was injured by pancreatic cancer or thyroid cancer from Kombiglyze, you should contact our law firm immediately. You may be entitled to compensation by filing a lawsuit and we can help.

Attention Lawyers:  Schmidt & Clark, LLP considers a referral from another lawyer to be one of the greatest compliments. Our law firm has built a reputation for success and accepts a number of case referrals on a regular basis. We do not publish prior verdicts or settlements on our website. If you would like to refer us a case or for us to send you a profile of prior award judgments or average referral fees, please fill out the form below.

Toll Free 24 hrs/day (866) 588-0600

Awards and Recognitions